摘要
目的 :观察冠心病患者冠状动脉内支架 (ICS)安置术后外周血中纤溶和前列腺素水平的变化及其临床意义。方法 :将 2 4例患者分为肝素涂层支架组 (n=9)和普通支架组 (n=15 ) ,测定 ICS术前、术后 2 ,2 4h,7d血浆血栓素B2 (TXB2 )、6 -酮 -前列腺素 F1α(PGF1α)、组织型纤溶酶原激活物 (t- PA)及其抑制物 (PAI- 1)的变化。结果 :肝素支架组与普通支架组术后 T X B2 ,PGF1α明显升高 ,术后 2 4h达高峰 ;t- PA与 PAI- 1术后无明显变化。结论 :ICS术后确有血小板活化 ,纤溶活性变化不大。肝素支架组与普通支架组并无显著差别。
AIM: To study the active changes of the fibrinolysis and the prostaglandin undergoing introcoronary stent (ICS)in the patients with coronary heart disease in order to guide the clinical drug usage. METHODS: The patients were divided into heparin coated stent (n=9)and non coated stent (n=15) groups and we determined the concentrations of thromboxane B 2(TXB 2), 6 Keto prostaglandin F 1α (6 Keto PGF 1α ), tissue type plasminogen activator (tPA)and plasminogen activator inhibitor 1(PAI 1)in 2,24 hours and 7 days after ICS. RESULTS: Both of the TXB 2 and 6 Keto PGF 1α were higher after ICS than before, rising to the peak at 24, but tPA and PAI 1 had no significant changes. CONCLUSION: Platelet may be activated after ICS and the fibrinolysis were the same as before. There are no significant differences between the heparin coated stent and non coated stent groups.
出处
《心脏杂志》
CAS
2000年第4期263-264,共2页
Chinese Heart Journal
关键词
冠状动脉疾病
支架
纤溶酶原激活剂
前列腺素
coronary disease
stent
tissue type plasminogen activator
prostaglandin